AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RUXOLITINIB
11 registrations across 4 African markets— 8 active
Markets with RUXOLITINIB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Jakavi 5mg Tablet | 🇰🇪Kenya | NVS Kenya Limited | active | Sept 2030 |
| Jakavi 15mg Tablet | 🇰🇪Kenya | NVS Kenya Limited | active | Sept 2030 |
| Jakavi 20mg Tablet | 🇰🇪Kenya | NVS Kenya Limited | active | Sept 2030 |
| JAKAVI Comprimé / 5 mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Apr 2019 |
| JAKAVI Comprimé / 15 mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Apr 2019 |
| JAKAVI Comprimé / 20 mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Apr 2019 |
| RUXOLITINIB ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | NOVARTIS PHARMA SERVICES INC | active | — |
| RUXOLITINIB ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | NOVARTIS PHARMA SERVICES INC | active | — |
| RUXOLITINIB ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | NOVARTIS PHARMA SERVICES INC | active | — |
| Jakavi Tablets | 🇹🇿Tanzania | NVS Kenya Limited | active | — |
| RUXOLITINIB ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | NOVARTIS PHARMA SERVICES INC | active | — |
RUXOLITINIB in Africa — Regulatory Overview
RUXOLITINIB is registered across 4 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Kenya, Tunisia, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.